HSPB1 and breast carcinoma: As for breast cancer, Hsp27 was demonstrated to be overexpressed in the aggressive forms, e.g., higher levels in tumors with lymph node metastasis compared to tumors without lymph node metastasis (6), while its value as a prognostic indicator remains arguable (7–9).